(Fwd) Returned mail: User unknown

George L. Wolff gwolff at NCTR.FDA.GOV
Mon Feb 23 15:51:34 EST 1998


------- Forwarded Message Follows -------
Date:          Mon, 23 Feb 1998 14:32:57 -0500 (EST)
From:          Mail Delivery Subsystem <MAILER-DAEMON at glaxowellcome.com>
Subject:       Returned mail: User unknown
To:            <gwolff at NCTR.FDA.GOV>

The original message was received at Mon, 23 Feb 1998 14:32:55 -0500 (EST)
from uucp at localhost

   ----- The following addresses have delivery notifications -----
<PatronID at glaxowellcome.com>  (unrecoverable error)

   ----- Transcript of session follows -----
... while talking to ussun2m.glaxo.com.:
>>> RCPT To:<PatronID at glaxowellcome.com>
<<< 550 <PatronID at glaxowellcome.com>... User unknown
550 <PatronID at glaxowellcome.com>... User unknown

   ----- Original message follows -----

Received: by firewall1-int.glaxowellcome.com id OAA15183; Mon, 23 Feb 1998 14:32:55 -0500 (EST)
Message-Id: <199802231932.OAA15183 at firewall1-int.glaxowellcome.com>
Received: from ntet.nctr.fda.gov(150.148.176.3) by firewall1.glaxo.com via smap (3.2)
	id xma015071; Mon, 23 Feb 98 14:32:17 -0500
Received: from EFS.NCTR.FDA.GOV by ntet.nctr.fda.gov with SMTP;
          Mon, 23 Feb 1998 13:20:56 -0600
Received: from EFS/SpoolDir by EFS.NCTR.FDA.GOV (Mercury 1.21);
    23 Feb 98 13:20:57 +1800
Received: from SpoolDir by EFS (Mercury 1.21); 23 Feb 98 13:20:35 +1800
From: "George L. Wolff" <gwolff at NCTR.FDA.GOV>
Organization: N.C.T.R.
To: "Your Name" <PatronID at glaxowellcome.com>
Date: Mon, 23 Feb 1998 13:20:28 CST
MIME-Version: 1.0
Content-type: text/plain; charset=US-ASCII
Content-transfer-encoding: 7BIT
Subject: Re: question on definitions
X-Confirm-Reading-To: "George L. Wolff" <gwolff at NCTR.FDA.GOV>
X-pmrqc: 1
Priority: normal
In-reply-to: <01bd3e51$86b0d1d0$bb813398 at us0073270>
X-mailer: Pegasus Mail for Win32 (v2.54)

Pharmacogenetics   - The formal structural  genetics of genes 
affecting toxic responsivity.

Pharmacogenomics -  The functional (physiological, metabolic, i.e. 
phenotypical)  effect(s) of the expression of the above genes.    


> To:            toxicol at net.bio.net
> From:          "Your Name" <PatronID at glaxowellcome.com>
> Subject:       question on definitions
> Date:          20 Feb 1998 22:47:49 GMT

> Any ideas on how to differentiate between "Pharmacogenetics" and "
> Pharmacogenomics"? Throw in your concepts, it doesn't have to be a polished
> definition.
> 
> 
> 
George L. Wolff, Ph.D.
Tel: (870) 543-7522
FAX: (870) 543-7635
Division of Biochemical Toxicology 
NCTR       HFT-110    
3900 NCTR Road
Jefferson, AR 72079-9502
















George L. Wolff, Ph.D.
Tel: (870) 543-7522
FAX: (870) 543-7635
Division of Biochemical Toxicology 
NCTR       HFT-110    
3900 NCTR Road
Jefferson, AR 72079-9502


















More information about the Toxicol mailing list